This site is a newly developed residential area, a high ground overlooking the sea near the city of Kobe, Japan. The development took place in recent years, and small-scale individual houses are lined up all around the neighborhood. The house-building industr…
Acorda (ACOR) beat earnings and revenue estimates in the fourth quarter of 2019.
Immunomedics (IMMU) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.
The project is a rework of an on-going hotel construction from the previous design that actually has already in topping-off position. Basically the client wanted to recompose the almost finish facade to seamlessly connect all the seemingly undesired result, s…
Acorda (ACOR) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Acorda Therapeutics (ACOR) closed the most recent trading day at $0.93, moving -0.11% from the previous trading session.
Acorda (ACOR) delivered earnings and revenue surprises of 63.41% and 11.88%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Holders of ETF shares should not expect to have to engage in company/stock-specific research. Yet some of the most popular ETFs out there today require holders to do just that? Are you doing your homework? If not, you may be ambushed by the FANG/FANMAG factor.
Acorda (ACOR) delivered earnings and revenue surprises of -45.71% and -28.58%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Designed and built by 2m26, an architecture and artist studio based in Kyoto, Japan, “2m26 Kyoto House” is a home, an office, a wood working atelier and an event space. 2m26 entirely renovated a hundred year-old Kyoto nagaya 長屋 house. Nagaya houses were built…
Acorda (ACOR) reports lower-than-expected loss in the fourth quarter while revenues beat estimates.
Q4 2019 Acorda Therapeutics Inc Earnings Call
S&P; Dow Jones Indices will make the following changes to the S&P; 500, S&P; 100, S&P; MidCap 400, and S&P; SmallCap 600 effective prior to the opening on Tuesday, May 12:
NDT HH Home is located in a densely populated area in Bac Ninh. The project has an area of 76m2 (6.3m x 12m) and the main façade is north. This is a typical Vietnamese “Tube house” with some limitations. Firstly, the only exposed part of the house is the st…
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2020 update and financial results on Tuesday, May 5 at 4:30 p.m. ET. To participate in the conference call, …
During Acorda's (ACOR) upcoming Q1 earnings call, investor focus will be on the sales uptake of its newly-launched Parkinson's disease drug, Inbrija.
Perched on a woodland bluff overlooking Lake Michigan, this home, designed in collaboration with Environment Architects (AOR) of Traverse City, MI, is an assemblage of three offset structures that play off each other— the ‘gathering’ structure contains the li…
A unique project in its context, this house is located in a neighborhood of Pune that has abundant greenery. The apt use of natural elements in its creation ― such as water bodies, bridges, stone walls, and landscaped areas on all levels ― helps it merge seam…
ETFs are supposed to be top-down portfolios oriented toward an asset class, a region, a line of business or a general combination of these. Holders of ETF share
Save money and keep your bike running better by doing your own maintenance
During Acorda's (ACOR) Q4 earnings call, investor focus will be on the sales uptake of its newly-launched Parkinson's disease drug Inbrija.
Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the first quarter ended March 31, 2020.
Acorda (ACOR) delivered earnings and revenue surprises of -45.71% and -28.58%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Nabriva (NBRV) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Acorda (ACOR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mallinckrodt (MNK) begins rolling submission of BLA for StrataGraft regenerative skin tissue therapy to the FDA for addressing adult patients with deep partial-thickness thermal burns. Stock rises.
Acorda Therapeutics (ACOR) closed the most recent trading day at $1.06, making no change from the previous trading session.
Acorda's (ACOR) earnings and revenues fall shy of estimates in the first quarter of 2020. The company withdraws revenue view for its Parkinson's disease drug Inbrija due to the ongoing COVID-19 pandemic.
Axsome's (AXSM) AXS-07 achieves both regulatory co-primary endpoints in the phase III INTERCEPT study for the early treatment of migraine.
The FDA on Thursday approved a Sunovion Pharmaceuticals treatment for Parkinson’s disease, giving patients a new way to take an old drug. The Sunovion product, Kynmobi, is a formulation of apomorphine hydrochloride, a drug that treats “off” episodes experi…
Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2020 update and financial results on Tuesday, May 5 at 4:30 p.m. ET.
New Strong Buy Stocks for March 30th
Located on the outskirts of Tangerang, Karawaci, one of the cities next to Jakarta, Tresno is the design of a simple tropical house in Jakarta. It’s simultaneously designed by the Geomancy principle creating 9 squares of the grid which forbids and allows some…
It is located in a neighborhood in Pilar, in the Province of Buenos Aires, Argentina and located on land with a slight unevenness and with excellent open views of the Golf course at the bottom of the 50 meter lot. long, and with a north orientation that allow…
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the first quarter ended March 31, 2020. “As we continue navigating the unprecedented operating environment created…